LifeStance Health Group, Inc. (LFST) Tops Q1 EPS by 3c ; Offers Guidance

LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q1 EPS of $0.04, $0.03 better than the analyst estimate of $0.01. Revenue for the quarter came in at $403.48 million versus the consensus estimate of $387.43 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2026 revenue of $1.64-1.68 billion, versus the consensus of $1.63 billion.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Lockheed Martin wins $83 million Army missile contract
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg